COVID-19 vaccines generated economic benefits worth USD 60 to USD 809 for every dollar invested in their development and distribution, a global study of 173 countries has found. However, high-income countries gained more due to earlier access and faster rollouts, while delayed vaccine availability limited benefits in poorer nations.